Search research articles
Contact Us
Filters
Showing results (301-310 of 489) with videos related to
Page
of 49
Sort By:
Brain Sciences
|
August 26, 2022
Changes in Oral Microbial Diversity in a Piglet Model of Traumatic Brain Injury
Julie Heejin Jeon, Jeferson M Lourenco, Madison M Fagan, et al.
Diabetes Care
|
March 6, 2014
Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial
Bruce A Perkins, David Z I Cherney, Helen Partridge, et al.
Neurobiology of Aging
|
December 12, 2018
Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network
Aurélie Bussy, B Joy Snider, Dean Coble, et al.
Circulation
|
December 17, 2013
Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus
David Z I Cherney, Bruce A Perkins, Nima Soleymanlou, et al.
Pain Medicine (Malden, Mass.)
|
February 27, 2015
Evaluation of a telementoring intervention for pain management in the Veterans Health Administration
Joseph W Frank, Evan P Carey, Katherine M Fagan, et al.
Journal of Clinical and Experimental Neuropsychology
|
January 17, 2022
Sharper in the morning: Cognitive time of day effects revealed with high-frequency smartphone testing
Hannah Wilks, Andrew J Aschenbrenner, Brian A Gordon, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
December 21, 2018
Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease
Guoqiao Wang, Chengjie Xiong, Eric M McDade, et al.
Biological Psychiatry
|
February 20, 2014
Phosphorylated tau-Aβ42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer's disease in multiplex immunoassay panels of cerebrospinal fluid
Oscar Harari, Carlos Cruchaga, John S K Kauwe, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 18, 2021
Network dysfunction in cognitively normal APOE ε4 carriers is related to subclinical tau
Omar H Butt, Karin L Meeker, Julie K Wisch, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 11, 2008
Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition
John S K Kauwe, Carlos Cruchaga, Kevin Mayo, et al.
Page
of 49
Search research articles
Search
Showing results (301-310 of 489) with videos related to
Sort By:
Page
of 49
Brain Sciences
|
August 26, 2022
Changes in Oral Microbial Diversity in a Piglet Model of Traumatic Brain Injury
Julie Heejin Jeon, Jeferson M Lourenco, Madison M Fagan, et al.
Diabetes Care
|
March 6, 2014
Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial
Bruce A Perkins, David Z I Cherney, Helen Partridge, et al.
Neurobiology of Aging
|
December 12, 2018
Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network
Aurélie Bussy, B Joy Snider, Dean Coble, et al.
Circulation
|
December 17, 2013
Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus
David Z I Cherney, Bruce A Perkins, Nima Soleymanlou, et al.
Pain Medicine (Malden, Mass.)
|
February 27, 2015
Evaluation of a telementoring intervention for pain management in the Veterans Health Administration
Joseph W Frank, Evan P Carey, Katherine M Fagan, et al.
Journal of Clinical and Experimental Neuropsychology
|
January 17, 2022
Sharper in the morning: Cognitive time of day effects revealed with high-frequency smartphone testing
Hannah Wilks, Andrew J Aschenbrenner, Brian A Gordon, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
December 21, 2018
Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease
Guoqiao Wang, Chengjie Xiong, Eric M McDade, et al.
Biological Psychiatry
|
February 20, 2014
Phosphorylated tau-Aβ42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer's disease in multiplex immunoassay panels of cerebrospinal fluid
Oscar Harari, Carlos Cruchaga, John S K Kauwe, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 18, 2021
Network dysfunction in cognitively normal APOE ε4 carriers is related to subclinical tau
Omar H Butt, Karin L Meeker, Julie K Wisch, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 11, 2008
Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition
John S K Kauwe, Carlos Cruchaga, Kevin Mayo, et al.
Page
of 49